C4 Therapeutics
CCCC
CCCC
117 hedge funds and large institutions have $229M invested in C4 Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.22% less ownership
Funds ownership: 82.31% → 80.09% (-2.2%)
35% less capital invested
Capital invested by funds: $353M → $229M (-$124M)
Holders
117
Holding in Top 10
–
Calls
$200K
Puts
$21K
Top Buyers
| 1 | +$5.9M | |
| 2 | +$4.19M | |
| 3 | +$2.87M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.47M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.08M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$6.72M | |
| 3 | -$5.3M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$4.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.54M |